IGKV2-23: A Potential Drug Target for Autoimmune Diseases (G28924)

Target Name: IGKV2-23

NCBI ID: G28924

Other Name(s): immunoglobulin kappa variable 2-23 (pseudogene) | Immunoglobulin kappa variable 2-23 (pseudogene) | IGKV223 | A24

IGKV2-23: A Potential Drug Target for Autoimmune Diseases

IGKV2-23 (Immunoglobulin Kappa Variable 2-23) is a unique gene that has been identified in various studies as having potential as a drug target or biomarker. The gene is located on chromosome 14 and encodes a protein known as IgKV2-23.

IGKV2-23 is a member of the Ig superfamily, which is a group of proteins that are characterized by the presence of a constant and variable region. The constant region consists of 21 amino acids, while the variable region consists of 89 amino acids. The protein encoded by IGKV2-23 belongs to the kappa class of Ig proteins, which are one of the five classes of antibodies produced by B cells.

IGKV2-23 has been shown to play a role in various biological processes, including immune response, inflammation, and autoimmune diseases. For example, studies have shown that IGKV2-23 is involved in the regulation of T cell development and function. It has also been shown to play a role in the development of multiple sclerosis, an autoimmune disease that affects the central nervous system.

One of the key reasons why IGKV2-23 has potential as a drug target is its involvement in the immune response. IGKV2-23 has been shown to play a role in the regulation of T cell development and function, which are critical for the immune response.

IGKV2-23 has been shown to control the development and function of T cells, which are a critical part of the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, and they are crucial for fighting off infections and diseases.

Studies have shown that IGKV2-23 plays a role in the regulation of T cell development and function by controlling the production of T cells from stem cells. IGKV2-23 has been shown to use a unique mechanism to regulate T cell development, which involves the production of a protein called NF-kappa-B.

NF-kappa-B is a protein that plays a critical role in various cellular processes, including inflammation and immune response. It is composed of two subunits, p65 and p50, which are involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation.

IGKV2-23 has been shown to use the production of NF-kappa-B to regulate T cell development and function. It does this by binding to a protein called STAT3, which is a protein that is involved in the regulation of NF-kappa-B activity. This interaction between IGKV2-23 and STAT3 allows IGKV2-23 to regulate the production of T cells from stem cells.

IGKV2-23 has also been shown to play a role in the regulation of T cell responses to foreign substances. For example, studies have shown that IGKV2-23 is involved in the regulation of the delayed-type hypersensitivity response (DTH), which is a type of immune response that is triggered by the presence of a foreign substance in the body.

IGKV2-23 has been shown to play a role in the regulation of T cell responses to foreign substances by controlling the production of T cells from stem cells. It does this by binding to a protein called STAT3, which is involved in the regulation of NF-kappa-B activity. This interaction between IGKV2-23 and STAT3 allows IGKV2-23 to regulate the production of T cells from stem cells and

Protein Name: Immunoglobulin Kappa Variable 2-23 (pseudogene)

More Common Targets